We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$224B
AUM Growth
+$21B
Cap. Flow
+$7.48B
Cap. Flow %
3.33%
Top 10 Hldgs %
24.57%
Holding
10,190
New
1,427
Increased
4,227
Reduced
3,278
Closed
1,044

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$798M
2
T icon
AT&T
T
+$527M
3
MCHP icon
Microchip Technology
MCHP
+$472M
4
NFLX icon
Netflix
NFLX
+$446M
5
PNC icon
PNC Financial Services
PNC
+$444M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$694M
2
KEY icon
KeyCorp
KEY
+$401M
3
DE icon
Deere & Co
DE
+$322M
4
CSX icon
CSX Corp
CSX
+$318M
5
NXPI icon
NXP Semiconductors
NXPI
+$314M

Sector Composition

Rank Sector Weight
1 Financials 5.93%
2 Technology 4.66%
3 Healthcare 4.45%
4 Industrials 4.14%
5 Consumer Discretionary 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIPT icon
8376
Tiptree Inc
TIPT
$672M
$108K ﹤0.01%
+16,546
New +$110K
LUMO
8377
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$108K ﹤0.01%
5,022
-3,241
-39% -$98.6K
NETI
8378
DELISTED
Eneti Inc.
NETI
$108K ﹤0.01%
1,603
-21,535
-93% -$1.4M
KDNY
8379
CALL
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$108K ﹤0.01%
+2,940
New +$94.4K
ROYT
8380
CALL
DELISTED
PACIFIC COAST OIL TRUST
ROYT
$108K ﹤0.01%
39,400
-15,400
-28% -$38.2K
LAB icon
8381
PUT
Standard BioTools
LAB
$280M
$107K ﹤0.01%
+14,300
New +$102K
NSLR
8382
Neostellar Capital Corp
NSLR
$278M
$107K ﹤0.01%
18,532
-23,598
-56% -$139K
CNTY icon
8383
Century Casinos
CNTY
$36M
$106K ﹤0.01%
+14,152
New +$113K
PTNR
8384
DELISTED
Partner Communications
PTNR
$106K ﹤0.01%
+20,620
New +$87K
ATRS
8385
DELISTED
Antares Pharma, Inc.
ATRS
$106K ﹤0.01%
31,495
-6,225
-17% -$19.2K
NBRV
8386
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$106K ﹤0.01%
157
+3
+2% +$2.13K
MNTX
8387
DELISTED
Manitex International, Inc.
MNTX
$106K ﹤0.01%
+10,036
New +$117K
APYX icon
8388
Apyx Medical
APYX
$128M
$105K ﹤0.01%
+14,773
New +$82.1K
ASYS icon
8389
PUT
Amtech Systems
ASYS
$281M
$105K ﹤0.01%
19,600
-1,400
-7% -$7.68K
CHRN
8390
ChronoScale Holdings
CHRN
$3.04B
$105K ﹤0.01%
200
+116
+138% +$57.8K
FTK icon
8391
Flotek Industries
FTK
$1.3B
$105K ﹤0.01%
7,324
-6,076
-45% -$94.1K
IBRX icon
8392
ImmunityBio
IBRX
$8.02B
$105K ﹤0.01%
28,455
+13,792
+94% +$43.6K
ARCO icon
8393
Arcos Dorados Holdings
ARCO
$1.67B
$104K ﹤0.01%
17,125
-9,152
-35% -$60.6K
DARE icon
8394
Dare Bioscience
DARE
$13.9M
$104K ﹤0.01%
8,862
+5,956
+205% +$80.2K
FAMI icon
8395
Farmmi Inc
FAMI
$4.79M
$104K ﹤0.01%
+8
New +$85.6K
GGB icon
8396
CALL
Gerdau
GGB
$9.3B
$104K ﹤0.01%
30,996
+15,498
+100% +$49.9K
WPRT
8397
PUT
Westport Fuel Systems
WPRT
$33.4M
$104K ﹤0.01%
3,450
-1,050
-23% -$29.8K
ROX
8398
DELISTED
Castle Brands, Inc.
ROX
$104K ﹤0.01%
+96,920
New +$110K
MXWL
8399
PUT
DELISTED
Maxwell Technologies Inc
MXWL
$104K ﹤0.01%
29,900
+12,000
+67% +$48.6K
OBE
8400
Obsidian Energy
OBE
$712M
$103K ﹤0.01%
15,667
-9,382
-37% -$67K

Similar funds

Ken Griffin's Q3 2018 Portfolio in Review

As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.

By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.

  • Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
  • Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
  • Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
  • Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
  • Ken Griffin opened 1,427 new positions and closed 1,044 in Q3 2018.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.

Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.